A
AVR
Anteris Technologies Global Corp. Common Stock
$6.26
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Anteris Technologies Global Corp. Common Stock in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
—
Yield
—
EPS
-$1.93
P/E
—
Data as of Oct 8
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: -$0.32
Nov 10
Posts
No posts about AVR yet.
About Anteris Technologies Global Corp. Common Stock
Anteris Technologies develops replacement heart valves. Its main project is DurAVR, a valve that doctors place through a small catheter in patients with a narrowed aortic valve, the main exit door of the heart. The company also sells tissue products used in surgical heart repair, but revenue is tiny so far. Most of its value rests on getting DurAVR approved and into hospitals.